¹Ú¼ÒÇö(Park So-Hyun) - National Cancer Center Department of Nuclear Medicine
±èżº(Kim Tae-Sung) - National Cancer Center Department of Nuclear Medicine
±è¼®±â(Kim Seok-Ki) - National Cancer Center Department of Nuclear Medicine
Abstract
18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a widely used imaging modality in the initial diagnosis of cancer, treatment response evaluation and detection of recurrence. Herein, we present the case of a 39-year-old female who presented right ptosis on the follow-up of breast cancer after surgery. Clinicians suspected Horner¡¯s syndrome, and the patient underwent FDG PET/CT for the evaluation of recurrence that could cause Horner¡¯s syndrome. FDG PET/CT demonstrated a focal hypermetabolic lesion in the right cervicothoracic junction area, corresponding to the preganglionic cervical sympathetic trunk. A subsequent needle biopsy was done, and the lesion was confirmed as metastatic ductal carcinoma. In this case, we could detect the exact location of the recurring lesion that caused Horner¡¯s syndrome using FDG PET/CT.
Å°¿öµå
FDG PET/CT, Horner¡¯s syndrome, Breast cancer, Recurrence
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This study report the first case in which FDG PET/CT revealed breast cancer recurrence presenting as Horner¡¯s syndrome.